$60,000 of HEARTFLOW INC. lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues related to Medicare reimbursement."
You can find more data on corporate lobbying on Quiver Quantitative.
HTFL Insider Trading Activity
HTFL insiders have traded $HTFL stock on the open market 10 times in the past 6 months. Of those trades, 1 have been purchases and 9 have been sales.
Here’s a breakdown of recent trading of $HTFL stock by insiders over the last 6 months:
- CAPITAL LIFE SCIENCES INVESTORS, LLC BAIN sold 2,000,000 shares for an estimated $56,100,000
- CAMPBELL ROGERS (Chief Medical Officer) has made 0 purchases and 3 sales selling 194,219 shares for an estimated $4,843,612.
- JOHN C.M. FARQUHAR (Chief Executive Officer) has made 0 purchases and 3 sales selling 45,124 shares for an estimated $1,153,563.
- JEFFREY C LIGHTCAP purchased 40,000 shares for an estimated $1,053,680
- JULIE A CULLIVAN has made 0 purchases and 2 sales selling 17,122 shares for an estimated $446,610.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
HTFL Hedge Fund Activity
We have seen 88 institutional investors add shares of HTFL stock to their portfolio, and 36 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPRICORN INVESTMENT GROUP LLC added 1,661,601 shares (+inf%) to their portfolio in Q4 2025, for an estimated $48,435,669
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 1,431,011 shares (+inf%) to their portfolio in Q4 2025, for an estimated $41,713,970
- CAPITAL INTERNATIONAL INVESTORS removed 1,297,423 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $37,819,880
- BAMCO INC /NY/ added 1,066,371 shares (+86.2%) to their portfolio in Q4 2025, for an estimated $31,084,714
- BLACKROCK, INC. added 1,032,570 shares (+333.6%) to their portfolio in Q4 2025, for an estimated $30,099,415
- WELLINGTON MANAGEMENT GROUP LLP added 1,014,006 shares (+20.8%) to their portfolio in Q4 2025, for an estimated $29,558,274
- CITADEL ADVISORS LLC added 871,223 shares (+230.7%) to their portfolio in Q4 2025, for an estimated $25,396,150
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
HTFL Analyst Ratings
Wall Street analysts have issued reports on $HTFL in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Wells Fargo issued a "Overweight" rating on 01/28/2026
- Stifel issued a "Buy" rating on 11/13/2025
- JP Morgan issued a "Overweight" rating on 11/13/2025
- Canaccord Genuity issued a "Buy" rating on 11/13/2025
To track analyst ratings and price targets for HTFL, check out Quiver Quantitative's $HTFL forecast page.
HTFL Price Targets
Multiple analysts have issued price targets for $HTFL recently. We have seen 4 analysts offer price targets for $HTFL in the last 6 months, with a median target of $37.5.
Here are some recent targets:
- Larry Biegelsen from Wells Fargo set a target price of $35.0 on 03/19/2026
- Robbie Marcus from JP Morgan set a target price of $35.0 on 03/19/2026
- William Plovanic from Canaccord Genuity set a target price of $43.0 on 03/19/2026
- Rick Wise from Stifel set a target price of $40.0 on 11/13/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
